Minnelide

Published date: 2020-09-17 11:27:14

Minnelide Structure
Share to Facebook Share to Twitter Share to Linkedin
Name Minnelide CAS# 1254702-87-8
Price ¥Inquiry/10mg ¥Inquiry/100mg ¥Inquiry/1g Purity 98.0%
Stocking
Period
Inquiry Stock In Stock
 Detail Product Information
Biological Activity:
Minnelide is a water-soluble prodrug of triptolide that is highly effective in reducing pancreatic tumor growth and spread, and improving survival; efficiently downregulates both CD133(-) and CD133(+) population in the tumors, resulting in a 60% decrease in tumor volume; also is very effective as a therapeutic option against Castration Resistant Prostate Cancer (CRPC)

Clinical Information:
Pancreatic Cancer
Phase 2 Clinical

Supplier/Manufacture

HmoBio

Chemsrc Level: Unverified
Tel: 18516630705
Address: 358 Kefu Road, Jiading District, Shanghai
Area: China
Contact: jason
Contact Phone #: 18516630705
Email: sales@hmobio.com
Website: https://www.hmobio.com
Annual Trade Volume:
Foreign Trade % of Sales:
Major partners:
HMO is a professional service provider of global scientific research chemicals and biologically active compounds. HMO's product range covers various inhibitors, agonists, compound libraries and biological antibodies. Committed to providing global customers with novel and complete high-quality small molecule active compounds. More than 30,000 specific inhibitors and agonists act on all target proteins in all signaling pathways such as epigenetics, PI3K/Akt/mTOR, apoptosis, MAPK, Wnt, etc., covering popular diseases such as cancer, neuroscience, and immunology Research areas.